Purchases and Sales Made in Q1 2024 in Cytek Biosciences, Inc. (CTKB)
This table provides information about the institutional ownership of Cytek Biosciences, Inc. (CTKB) during Q1 2024. The information is specifically focused on institutions that hold shares of Cytek Biosciences, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-52.6K- 69.12% |
$331K - $481K
|
23.5K
$101K
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-60K- 5.04% |
$377K - $549K
|
1.13M
$4.84M
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-62.2K- 42.13% |
$391K - $569K
|
85.4K
$366K
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-82.7K- 43.69% |
$520K - $757K
|
107K
$456K
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-153K- 76.88% |
$964K - $1.4M
|
46.1K
$197K
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-354K- 1.99% |
$2.23M - $3.24M
|
17.4M
$74.6M
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-513K- 85.73% |
$3.23M - $4.7M
|
85.4K
$366K
|